Previous 10 | Next 10 |
Image source: The Motley Fool. Amarin Plc (NASDAQ: AMRN) Q4 2022 Earnings Call Mar 01, 2023 , 8:00 a.m. ET Operator Continue reading For further details see: Amarin Plc (AMRN) Q4 2022 Earnings Call Transcript
Amarin press release ( NASDAQ: AMRN ): Q4 Non-GAAP EPS of $0.02 beats by $0.02 . Revenue of $90.25M (-37.5% Y/Y) beats by $1.07M . For further details see: Amarin Non-GAAP EPS of $0.02 beats by $0.02, revenue of $90.25M beats by $1.07M
-- Company Delivers Positive Free Cash Flow in Fourth Quarter 2022 Following U.S. Revenue Stabilization -- -- Previously Announced Cost Savings Program On-Track to Exceed $100 Million Target -- -- European, International Strategies Advancing At-Pace with Significant Progress Thr...
Summary Positive cash flow in the U.S. for the 3rd quarter. European launch of VASCEPA began in the 4th quarter. Amarin came under new management in 2021. For further details see: Positive Events Are Lining Up At Amarin
Despite a mixed performance for the overall markets during Tuesday's midday trading, the release of quarterly results provided notable trading fodder for many individual stocks. This included Gogo ( NASDAQ: GOGO ) and Progyny ( PGNY ), which surged in the wake of their respective quar...
Amarin ( NASDAQ: AMRN ) is scheduled to announce Q4 earnings results on Wednesday, March 1st, before market open. The consensus EPS Estimate is $0.00 (-100.0% Y/Y) and the consensus Revenue Estimate is $89.18M (-38.3% Y/Y). Over the last 2 years, AMRN has beaten EPS estimate...
Amarin Corp. ( NASDAQ: AMRN ) shares are up ~8% in Tuesday afternoon trading after Sarissa Capital Management, the company's largest shareholder, had seven of its backed individuals elected to the board and current chairman Per Wold-Olsen tossed. The new board will have 15 members...
Sarissa honored to have received 100 million more votes than Amarin board Sarissa Capital Management LP today issued the following statement regarding Amarin Corporation plc (NASDAQ: AMRN): Amarin shareholders have sent a loud and clear message repudiating the incumbent Amarin board...
DUBLIN, Ireland and BRIDGEWATER. N.J., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today announced that, based on the preliminary voting results provided by its proxy solicitors following the Company’s 2023...
Amarin ( NASDAQ: AMRN ) is licensing exclusive rights to Vazkepa to CSL Seqirus to secure pricing and reimbursement, and sell the heart drug in Australia and New Zealand. Under the agreement, Amarin will receive an upfront payment and be eligible for event-related miles...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
2024-07-31 14:15:16 ET Image source: The Motley Fool. Amarin Plc (NASDAQ: AMRN) Q2 2024 Earnings Call Jul 31, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Amarin Plc (AMRN) Q2 2024 Earnings Call Transcript
Dayforce Inc. (DAY) is expected to report $0.18 for Q2 2024 D/B/A Compass Diversified Holdings Shares of Beneficial Interest (CODI) is expected to report $0.44 for Q2 2024 Aurora Innovation Inc. (AUR) is expected to report for Q2 2024 Autohome Inc. American Depositary Shares each repr...
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...